Nattokinase 100mg 180sg by Allergy Research Group
Nattokinase 100mg 180sg is a cardiovascular health support product.* Designed by Allergy Research Group, it was the first nattokinase supplement to be introduced in the US market.* Thanks to this, it not only paved the way for other alternatives but also established the standards for other potent supplements like this.*
Who Should Consider Nattokinase 100mg 180sg?
Nattokinase 100mg 180sg by Allergy Research Group might be a good choice if you:
- lead a stressful lifestyle*
- smoke a lot*
- consume mainly processed foods*
- lack physical activity in everyday life*
- want to promote your general heart & vein health and wellness*
Nattokinase 100mg 180sg by Allergy Research Group—Effects
Nattokinase 100mg 180sg by Allergy Research Group may:
- support healthy blood flow and circulation*
- help maintain healthy fibrin levels*
- promote healthy blood pressure*
- support your overall cardiovascular health*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about this product.
Recommendation:
Allergy Research Group suggests taking 1 Nattokinase 100mg softgel two times daily, or as directed by a healthcare practitioner.
Serving Size: 1 softgel
Servings Per Container: 180
Amount Per Serving:
Nattokinase NSK-SD® (2000 FU) 100 mg
Other ingredients: Soybean oil, gelatin, glycerin, soybean lecithin, glycerin fatty acid ester, beeswax.
Variations in product color may occur. Keep Nattokinase 100mg by Allergy Research Group in a cool, dry place, tightly capped.
Cautions:
Do not take if you have any condition associated with bleeding.*
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
References:
- Calvino, N. (2002). The enzyme of enzymes—Nattokinase. Townsend Letter for Doctors and Patients, (232).
Murakami, K., Yamanaka, N., Ohnishi, K., Fukayama, M., & Yoshino, M. (2012). Inhibition of angiotensin I converting enzyme by subtilisin NAT (nattokinase) in natto, a Japanese traditional fermented food. Food & Function, 3(6), 674–678. https://doi.org/10.1039/c2fo10245e - Yatagai, C., Maruyama, M., Kawahara, T., & Sumi, H. (2008). Nattokinase-promoted tissue plasminogen activator release from human cells. Pathophysiology of Haemostasis and Thrombosis, 36(5), 227–232. https://doi.org/10.1159/00019996631
- Fujita, M., Ohnishi, K., Takaoka, S., Ogasawara, K., & Kurata, Y. (2011). Antihypertensive effects of continuous oral administration of nattokinase and its fragments in spontaneously hypertensive rats. Biological & Pharmaceutical Bulletin, 34(11), 1696–1701. https://doi.org/10.1248/bpb.34.1696